Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

K D Hove, Charlotte Brøns, Kai Erik Vinther Færch, S S Lund, J S Petersen, A E Karlsen, Pia Rossing, J F Rehfeld, A Vaag

34 Citationer (Scopus)

Abstract

Recent studies suggest that proton pump inhibitor treatment may increase insulin secretion and improve glucose metabolism in type 2 diabetes. In a randomised double-blind prospective placebo-controlled 2 × 2 factorial study, we examined the effect of esomeprazole on insulin secretion, HbA(1c) and cardiovascular risk factors in type 2 diabetes.
OriginalsprogEngelsk
TidsskriftDiabetologia
Vol/bind56
Udgave nummer1
Sider (fra-til)22-30
Antal sider9
ISSN0012-186X
DOI
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study'. Sammen danner de et unikt fingeraftryk.

Citationsformater